Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Virtual Congress 2020

Daiichi Sankyo - Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)

Expanding the horizon for the treatment of lung cancer with ADCs

Date

20 Nov 2020

Session

Daiichi Sankyo - Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)

Topics

Targeted Therapy

Tumour Site

Presenters

Keunchil Park

Authors

K. Park

Author affiliations

  • Ivision Of Hematology/oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 06351 - Seoul/KR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Tony S.K. Mok

Session: Daiichi Sankyo - Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)

Resources:

Webcast

Live Q&A + summary and close

Presenter: Hyun Cheol Chung

Session: Daiichi Sankyo - Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.